SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004744
Filing Date
2021-11-18
Accepted
2021-11-17 20:35:45
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtyx-20210930.htm   iXBRL 10-Q 3771227
2 EX-10.1 vtyx-ex10_1.htm EX-10.1 306991
3 EX-10.2 vtyx-ex10_2.htm EX-10.2 487947
4 EX-31.1 vtyx-ex31_1.htm EX-31.1 19947
5 EX-31.2 vtyx-ex31_2.htm EX-31.2 19968
6 EX-32.1 vtyx-ex32_1.htm EX-32.1 12528
7 EX-32.2 vtyx-ex32_2.htm EX-32.2 12549
  Complete submission text file 0000950170-21-004744.txt   12164820

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtyx-20210930_lab.xml EX-101.LAB 467237
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtyx-20210930_cal.xml EX-101.CAL 50825
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtyx-20210930_pre.xml EX-101.PRE 375284
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtyx-20210930_def.xml EX-101.DEF 227463
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtyx-20210930.xsd EX-101.SCH 53958
13 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20210930_htm.xml XML 2068531
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 211422306
SIC: 2834 Pharmaceutical Preparations